Key result
Quetiapine augmentation was associated with significantly lower heart rate variability (total power, very low frequency, and low frequency) compared to antidepressants alone or no medication.
Why the study?
Does the use of antidepressants or quetiapine reduce heart rate variability in psychiatric patients without psychotic symptoms?
Cross-Sectional (n=94)
Does the use of antidepressants or quetiapine reduce heart rate variability in psychiatric patients without psychotic symptoms?
Quetiapine augmentation, but not antidepressants alone, is associated with a significant decrease in heart rate variability in non-psychotic psychiatric patients.
Answers are grounded in this paper and cite their sources.
Quetiapine augmentation may lower HRV; hypothesis-generating for cardiovascular risk and requires prospective studies.
Introduction: The autonomic effects of antidepressants and quetiapine on heart rate variability (HRV) are inconsistent based on past studies. The aim of this study was to explore their influence on the HRV of psychiatric patients without psychotic symptoms. Methods: A total of 94 patients with depression, anxiety, or somatic symptoms, were recruited into this study. Based on their medication, 4 groups were identified: the no antidepressant group (n=19), the SSRI group (using sertraline or escitalopram, n=53), the other antidepressants group (using venlafaxine or mirtazapine, n=9), and the augmentation group (AG, using an antidepressant+quetiapine, n=13). The HRV of the 4 groups were compared. The correlations between HRV and the medication(s) used were clarified. Results: Among the 4 groups, the AG had the lowest HRV with its total power (TP), very low frequency power (VLF) and low frequency power (LF) of HRV being significantly different from those of the other groups. Age and using quetiapine were found to be negatively correlated with TP, VLF and LF. With this study group, the autonomic effects of antidepressants were found not to be significant. Discussion: Among psychiatric patients without psychotic symptoms, quetiapine causes an overt decrease in HRV.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2016) conducted a cross-sectional in Depression, anxiety, or somatic symptoms without psychotic symptoms (n=94). Quetiapine augmentation vs. No antidepressant, SSRI, or other antidepressants was evaluated on Heart rate variability (total power, very low frequency power, and low frequency power). Quetiapine augmentation was associated with significantly lower heart rate variability (total power, very low frequency, and low frequency) compared to antidepressants alone or no medication.
Synapse has enriched 10 related papers. Consider them for comparative context: